You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股异动 | 亿胜生物科技(1061.HK)逆势大涨逾16% 股价创8个月新高
格隆汇 03-02 13:55
格隆汇3月2日丨亿胜生物科技(1061.HK)逆势拉升16.6%,报5.48港元创8个月新高价,总市值31.6亿港元。日前公司与Mitotech共同开发用于干眼症、含SkQ1之滴眼液美国药监局第二阶段三期试验取得正面结果。Mitotech目标于2022-2023年完成新药申请提交。在此前生物医药股港股大牛市的背景下,亿胜生物科技走势相对平淡,在近日大市回调的背景下股价异常活跃。值得一提的是,2月24日,港府计划印花税,引发市场暴跌,但公司却逆势大涨14%,今日香港财政司司长陈茂波称不排除进一步提高股票印花税,又导致市场大跌,公司再次逆势拉升。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account